Medicare Compliance & Reimbursement - 2004 Issue 30
Oncology: Oncologists Lack Information To Prepare For The Worst
Subscribe or sign in to view the full article.
Article Overview
This article explains why oncologists are struggling to plan for next year’s Medicare-related payment changes. It discusses CMS data timing and completeness, the uncertainty around reimbursement for cancer drugs and related office-based services, and a proposed legislative stopgap that oncologists and ASCO are watching closely. The piece is relevant to oncology practices, coding and reimbursement staff, and anyone tracking Medicare policy changes affecting chemotherapy administration and related support services.
Why This Topic Matters
Payment uncertainty can affect whether oncology practices can start or continue treatment regimens, how they staff office-based services, and how they prepare financially for upcoming Medicare changes. The article provides context for why providers are waiting on CMS pricing information and legislative action before making operational decisions.
What You Will Learn
- Why oncology practices are waiting for more complete Medicare pricing information
- How reimbursement uncertainty affects planning for drug treatment and office-based support services
- What legislative proposal oncologists are hoping will temporarily stabilize payment
- Why the timing of CMS releases matters for practice operations and budgeting
Who Should Read This
- Oncology practices
- Medical coders
- Billing staff
- Revenue cycle teams
- Practice managers
- Healthcare administrators
- Reimbursement specialists
Subscribe or sign in to view the full article.
Quick, Current, Complete - www.findacode.com